Table of Content

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Reasons for Doing this Study
Market Summary

Chapter 2 MENA Clinical Trial Industry Outlook
Global Clinical Trial Market Overview
MENA Share
Evolving MENA Clinical Trial Industry
Infrastructure and Resources: Bridging Gaps in Emerging Markets
Patient Recruitment Potential: Diverse Populations and High Recruitment Rates
Cost-Effectiveness
Regulatory Environment: Harmonization and Local Adaptations
Government Support and Investments
Impact of Regional Policies: Incentivizing Clinical Research
Collaborations Expand Regional Networks
Emerging Trends: Focus on Precision Medicine and Rare Diseases
Growing Demand in Oncology and Rare Diseases
Technological Advances: Digitalizing Clinical Operations
Understanding the MENA Clinical Trial Landscape

Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Regulatory Frameworks Driving Trial Feasibility
Growing Patient Population Enhancing Recruitment and Diversity
Technological Advances Streamlining Operations
Collaborations
Personalized Medicine Shaping Trial Design
Market Challenges
Complex Regulatory Landscape
Limited Patient Recruitment and Retention
Insufficient Infrastructure and Site Capacity
Limited Adoption of Digital Technologies
Competition for Key Therapeutic Areas
Market Opportunities
Regulatory Reforms Enabling Faster Approvals
Emerging Focus on Oncology and Rare Diseases
Public-Private Partnerships Boosting Research Capacity
Focus on Precision Medicine and Genomics

Chapter 4 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis, by Sponsor Type
Market Analysis, by Phase
Market Analysis, by Service Type
Market Analysis, by Study Type
Market Analysis, by Therapeutic Area

Chapter 5 Emerging Markets
Egypt
Overview
Clinical Trial Landscape Analysis
Observations
Kingdom of Saudi Arabia (KSA)
Overview
Clinical Trial Landscape Analysis
Observations
Lebanon
Overview
Clinical Trial Landscape Analysis
Observations
United Arab Emirates
Overview
Clinical Trial Landscape Analysis
Observations
Iran
Overview
Clinical Trial Landscape Analysis
Observations
\
Chapter 6 Russia-Ukraine War Impact Analysis
Overview
Supply Chain Disruptions
Regulatory Challenges
Patient Recruitment and Retention
Geopolitical Risks

Chapter 7 Competitive Landscape
Overview
Competitive Landscape
International CROs and Pharmaceutical Companies
Local CROs and Institutions
Academic and Research Institutions
Mapping of Clinical Trial Product Services
Recent Developments in Clinical Trials in the MENA Region

Chapter 8 Appendix
Methodology
Research Steps
Sources
Abbreviations



List of Figures

 

Summary Figure : MENA Market for Clinical Trials, by Country, 2023–2029
Figure 1 : Global Market for Clinical Trials, by Value, 2023–2029
Figure 2 : Share of the Global Clinical Trials Market Value, by Region, 2023
Figure 3 : Key Considerations for MENA Clinical Trials
Figure 4 : Market Dynamics of Clinical Trial Infrastructure in the MENA Region
Figure 5 : Share of Deaths, by Broad Cause, by Country, 2021
Figure 6 : Share of MENA Market for Clinical Trials, by Sponsor Type, 2023
Figure 7 : Share of MENA Market for Clinical Trials, by Phase, 2023
Figure 8 : Share of MENA Market for Clinical Trials, by Service Type, 2023
Figure 9 : Share of MENA Market for Clinical Trials, by Study Type, 2023
Figure 10 : Share of MENA Market for Clinical Trials, by Therapeutic Area, 2023
Figure 11 : Egyptian Market for Clinical Trials, by Value, 2023–2029
Figure 12 : BCC Recommendations for the Egyptian Market for Clinical Trials
Figure 13 : Saudi Arabian Market for Clinical Trials, by Value, 2023–2029
Figure 14 : BCC Recommendations for Saudi Arabian Clinical Trials
Figure 15 : Lebanese Market for Clinical Trials, by Value, 2023–2029
Figure 16 : BCC Recommendations for Lebanese Clinical Trials
Figure 17 : UAE Market for Clinical Trials, by Value, 2023–2029
Figure 18 : BCC Recommendations for the UAE Clinical Trials
Figure 19 : Iranian Market for Clinical Trials, by Value, 2023–2029
Figure 20 : BCC Recommendations for the Iranian Clinical Trials
Figure 21 : Share of MENA Market for Clinical Trials, by Stakeholder, 2024
Figure 22 : Recommendations for Companies Looking to Enter the MENA Clinical Trial Market
Figure 23 : Methodology Used in the MENA Clinical Trial Market

List of Tables


Summary Table : MENA Market for Clinical Trials, by Country, Through 2029
Table 1 : MENA Clinical Trial Analysis, by Study Status, Through 2024
Table 2 : Comparison of MENA Clinical Trial Regulations, Through 2024
Table 3 : Comparison of MENA Clinical Trial Regulations, Through 2024
Table 4 : MENA Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 5 : Regulatory Bodies for Conducting Clinical Trials in the MENA Region
Table 6 : Recent Technological Advances in the MENA Clinical Trial Market, 2023 and 2024
Table 7 : Recent Collaborations in the MENA Clinical Trial Market, 2024
Table 8 : Recent Developments in Clinical Trial Infrastructure in MENA, 2023 and 2024
Table 9 : Leading Causes of Death in MENA, by Country, 2021
Table 10 : Recent Developments in the MENA Region, 2023 and 2024
Table 11 : Recent Collaborations in the MENA Region, 2024
Table 12 : Leading MENA Countries for Clinical Trials, by Sponsor Type, Through 2024
Table 13 : MENA Market for Clinical Trials, by Sponsor Type, Through 2029
Table 14 : Leading MENA Countries for Clinical Trials, by Phase, Through 2024
Table 15 : MENA Market for Clinical Trials, by Phase, Through 2029
Table 16 : MENA Market for Clinical Trials, by Service Type, Through 2029
Table 17 : Leading MENA Countries for Clinical Trials, by Study Type, Through 2024
Table 18 : MENA Market for Clinical Trials, by Study Type, Through 2029
Table 19 : MENA Market for Clinical Trials, by Therapeutic Area, Through 2029
Table 20 : Egyptian Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 21 : Companies and Research Institutes for Clinical Trials in Egypt
Table 22 : Egyptian Market for Clinical Trials, by Value, Through 2029
Table 23 : Saudi Arabian Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 24 : Companies and Research Institutes for Clinical Trials in the KSA
Table 25 : Saudi Arabian Market for Clinical Trials, by Value, Through 2029
Table 26 : Lebanese Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 27 : Companies and Research Institutes for Clinical Trials in Lebanon
Table 28 : Lebanese Market for Clinical Trials, by Value, Through 2029
Table 29 : UAE Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 30 : Companies and Research Institutes for Clinical Trials in UAE
Table 31 : UAE Market for Clinical Trials, by Value, Through 2029
Table 32 : Iranian Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 33 : Companies and Research Institutes for Clinical Trials in Iran
Table 34 : Iranian Market for Clinical Trials, by Value, Through 2029
Table 35 : MENA Clinical Trials Product/Services Mapping Analysis
Table 36 : Recent Developments in the MENA Clinical Trial Market, 2020–2024
Table 37 : Information Sources in this Report
Table 38 : Abbreviations Used in this Report